Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020

SELL
$0.64 - $1.14 $17,616 - $31,378
-27,525 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$0.82 - $2.24 $108 - $295
132 Added 0.48%
27,525 $30,000
Q3 2019

Nov 07, 2019

BUY
$1.36 - $2.4 $37,254 - $65,743
27,393 New
27,393 $62,000
Q4 2018

Feb 11, 2019

SELL
$2.15 - $3.11 $39,177 - $56,670
-18,222 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$2.28 - $2.93 $12,831 - $16,490
-5,628 Reduced 23.6%
18,222 $51,000
Q2 2018

Aug 14, 2018

BUY
$2.02 - $2.55 $12,120 - $15,299
6,000 Added 33.61%
23,850 $59,000
Q1 2018

May 14, 2018

SELL
$2.21 - $4.16 $35,360 - $66,560
-16,000 Reduced 47.27%
17,850 $42,000
Q4 2017

Feb 14, 2018

BUY
$1.99 - $3.41 $28,656 - $49,104
14,400 Added 74.04%
33,850 $95,000
Q3 2017

Nov 13, 2017

SELL
$1.75 - $3.21 $962 - $1,765
-550 Reduced 2.75%
19,450 $54,000
Q2 2017

Aug 14, 2017

BUY
N/A
20,000
20,000 $35,000

Others Institutions Holding XXII

About 22nd Century Group, Inc.


  • Ticker XXII
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 214,784,992
  • Market Cap $19.3M
  • Description
  • 22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King n...
More about XXII
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.